| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 01/07/2009 | EP1220933B1 Purification of recombinant proteins fused to multiple epitopes |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1062245B1 A method of preparing products comprising inactivated yeasts or moulds and active vhh-type antibodies |
| 01/07/2009 | CN201176420Y Heat shock protein extraction column |
| 01/07/2009 | CN101341167A Process for the purification of macrolide antibiotics |
| 01/07/2009 | CN101341118A Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 01/07/2009 | CN101338305A Process for extracting superoxide dismutase and reduction glutathion from animal blood |
| 01/07/2009 | CN101337986A Artificial recombined hexon protein A, constructing method thereof and use |
| 01/07/2009 | CN100448990C Method for preparing pancreatic kallikrein using expanded bed adsorption technology and affinity chromatography |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/07/2009 | CN100448888C Haemostatically active preparation containing VWF and production thereof |
| 01/07/2009 | CN100448852C Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 01/06/2009 | US7473764 Protein composition obtained from a muscle source |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473680 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 01/06/2009 | US7473671 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
| 01/06/2009 | US7473535 Chemical reagents and methods for detection and quantification of proteins in complex mixtures |
| 01/06/2009 | US7473532 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 01/06/2009 | CA2400460C Mapping of differential display of proteins |
| 01/06/2009 | CA2370539C System and method for notating polymers |
| 01/06/2009 | CA2350141C A method for determining a mimotope sequence |
| 01/06/2009 | CA2181590C Peptomers with enhanced immunogenicity |
| 01/06/2009 | CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/01/2009 | US20090005544 Process for Making Soy Protein Isolates |
| 01/01/2009 | US20090005543 Protein-refolding material |
| 01/01/2009 | US20090005541 Gag binding protein |
| 01/01/2009 | US20090005536 Hybrid solid supports useful for oligonucleotide production |
| 01/01/2009 | US20090005257 Process for Recovering Polypeptides that Unfold Reversibly from a Polypeptide Repertoire |
| 01/01/2009 | US20090004696 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 01/01/2009 | US20090004684 Compositions and Methods for Detection and Quantification of Protein Oxidation |
| 01/01/2009 | US20090004242 Coatings and Biomedical Implants Formed From Keratin Biomaterials |
| 01/01/2009 | US20090004212 Tumour vaccines for MUC1-positive carcinomas |
| 12/31/2008 | WO2009002832A2 Inhibitors of ncca-atp channels for therapy |
| 12/31/2008 | WO2009000950A1 Method for the deblocking/deprotection of compounds obtained by solid phase synthesis |
| 12/31/2008 | WO2008133640A3 Disposable micropurification cards, methods, and systems thereof |
| 12/31/2008 | WO2008108941A3 Integrated photoactive peptides and uses thereof |
| 12/31/2008 | EP2009447A2 Apparatus for measuring high density lipoproteins and method of separating high density lipoproteins |
| 12/31/2008 | EP2009104A1 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 12/31/2008 | EP2008664A2 Modified proteins which bind extracellular matrix components |
| 12/31/2008 | EP2007808A2 Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions |
| 12/31/2008 | EP2007801A1 Binder for c-reactive protein |
| 12/31/2008 | EP2007794A1 Lysobactin amides |
| 12/31/2008 | EP2007786A2 Modified metallothioneins and methods for screening and treatment of diseases associated with oxidative stress |
| 12/31/2008 | EP2007427A2 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 12/31/2008 | EP1797117A4 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 12/31/2008 | EP1718760B1 Protein phosphorylation in c-src signaling pathways |
| 12/31/2008 | EP1718662A4 Multiplex detection probes |
| 12/31/2008 | EP1648923B1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 12/31/2008 | EP1482793B1 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria |
| 12/31/2008 | EP1448760B1 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 12/31/2008 | EP1268525B1 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 12/31/2008 | EP1266385B1 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
| 12/31/2008 | CN101333540A Photosynthetic bacteria expression system capable rapidly detecting exogenous protein expression and use thereof |
| 12/31/2008 | CN101333259A Preparation of <99m>Tc galactosyl human serum albumin fusion interferon of liver receptor developer and uses thereof |
| 12/31/2008 | CN101333247A Antimicrobial peptide separated from skin of Northeast China brown frog and applications in antibacterials |
| 12/31/2008 | CN101333245A Method for separating human serum albumin |
| 12/31/2008 | CN101333244A Protein purification by ion exchange chromatography |
| 12/31/2008 | CN101333243A Process for recovering polypeptides that unfold reversibly from a polypeptide repertoire |
| 12/31/2008 | CN101332292A Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain |
| 12/31/2008 | CN100447311C Method for developing crystal of protein |
| 12/31/2008 | CN100447150C Isolation of lectins |
| 12/31/2008 | CA2691199A1 Inhibitors of ncca-atp channels for therapy |
| 12/30/2008 | US7470783 Performing photochemical reactions on a surface; prepare chemical mixture, apply to surface, irradiate, monitor generation of reaction product; Blocking; high density arrays; activation |
| 12/30/2008 | US7470779 Process for decreasing aggregate levels of pegylated protein |
| 12/30/2008 | US7470774 Anti-pro1477 antibodies |
| 12/30/2008 | US7470670 Peptide inhibitors of cyclin-dependent kinase activity and uses thereof |
| 12/30/2008 | US7470432 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease |
| 12/30/2008 | US7470430 Modifications of HIV, ENV, GAG, and POL enhance immunogenicity for genetic immunization |
| 12/30/2008 | CA2218929C Compositions in glassy phase, stabilised by a sugar |
| 12/25/2008 | US20080319173 Blood group antigen fusion polypeptides and methods of use thereof |
| 12/25/2008 | US20080319170 Methods and Uses of Antibodies in the Purification of Interferon |
| 12/25/2008 | US20080319166 Treatment of implantable medical devices resistant to calcification |
| 12/25/2008 | US20080318858 comprises a modified amino acid sequence comprising one or more amino acid substitutions to an amino acid sequence; substitutions are selected from the group consisting of H98Y, E102K, E108K, E120K; use as complement inhibitor |
| 12/25/2008 | US20080318853 Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin |
| 12/25/2008 | US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 12/25/2008 | US20080318841 Method For Preparing a Factor H Concentrate and the Use Thereof in the Form of a Drug |
| 12/25/2008 | US20080318806 Device for chemical and biochemical reactions using photo-generated reagents |
| 12/25/2008 | US20080318338 Drug screening using a high affinity form of Heat Shock Protein-90 (HSP90) that has a 17-allylamino-geldanamycin (17-AAG) binding affinity |
| 12/25/2008 | US20080314831 Composite Materials Comprising Supported Porous Gels |
| 12/25/2008 | US20080314750 Method for Pre-Fractionation of Complex Samples |
| 12/24/2008 | WO2008156410A1 Polymer two phase system and use thereof |
| 12/24/2008 | WO2008156409A1 Separation method using polymer multi phase systems |
| 12/24/2008 | WO2008156124A1 Method for separation of immunoglobulin monomer |
| 12/24/2008 | WO2008154738A1 Azapeptides as cd36 binding compounds |
| 12/24/2008 | WO2008067271A3 Prevention of leaching of ligands from affinity-based purification systems |
| 12/24/2008 | WO2008066608A8 A secreted luciferase fluorescent protein conjugate nucleic acid construct and uses thereof |
| 12/24/2008 | WO2008060941A3 Expression system of nell peptide |
| 12/24/2008 | WO2008057652A3 A method to detect virus related immunological markers for the diagnosis of hepatitis c virus infection |
| 12/24/2008 | WO2008048570A3 Piwil2-related biomarkers and cell lines useful therewith |
| 12/24/2008 | WO2007092453A3 Igf-ir antagonists as adjuvants for treatment of prostate cancer |
| 12/24/2008 | WO2006088508A3 Cupredoxin derived transport agents and methods of use thereof |
| 12/24/2008 | EP2006302A2 Protein complex and process for production thereof |
| 12/24/2008 | EP2005183A1 Competitive enzyme linked immunosorbent assay (c-elisa) for the detection of a flavivirus specific antibody |
| 12/24/2008 | EP2004804A2 Processes for improved disulfide bond formation in recombinant systems |
| 12/24/2008 | EP2004689A2 Antibody purification |
| 12/24/2008 | EP2004672A2 A process for concentration of a polypeptide |
| 12/24/2008 | EP2004671A1 Two-phase precipitation of proteins |
| 12/24/2008 | EP2004670A1 Process for the manufacture of lysobactin derivatives |
| 12/24/2008 | EP2004666A2 Ras mutation and compositions and methods related thereto |